Monday, December 7, 2015

Endogastric Solutions Finds $50M

Redmond-based medical products developer EndoGastric Solutions, which is developing therapies for treating gastroesophageal reflux disease (GERD), has raised $50M in a fudning round, the company said last week. The funding came from CRG (formerly Capital Royalty L.P.), along with Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, Foundation Medical Partners, and Radius Ventures. The company said the new funds go towards commercialization and research and development. Skip Baldino is the President and CEO of EndoGastric Solutions.